Company news
Aptevo Therapeutics Inc. news in 2022
Aptevo Therapeutics Inc.'s news releases, calls and decks from 2022, newest first.
Aptevo Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
November 9, 2022
Aptevo Therapeutics Announces Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition
November 2, 2022
Aptevo Therapeutics Announces New Preliminary Remission Data on Four Additional Patients Enrolled in On-going APVO436 Dose Expansion Phase 1b Trial for the Treatment of Acute Myeloid Leukemia
June 8, 2022
Aptevo Therapeutics Announces Monotherapy Patient Received a Transplant in APVO436 Expansion Trial for the Treatment of Acute Myeloid Leukemia
March 28, 2022
Aptevo Therapeutics Reports 2021 Financial Results and Provides Business Update
March 23, 2022
Aptevo Therapeutics Earns $10 Million Non-Dilutive Milestone Payment on Sales of RUXIENCE, Provides Company Update
February 8, 2022